Company Updates

EpiAxis Therapeutics is pleased to announce it is commencing a pre-clinical collaboration focused on inhibiting Protein Kinase C theta (PKC theta), which could provide a potential new approach to trea

“Horizon 3 Biotech is excited to announce the addition of Dr.Tam Nguyen to our Investment Committee. Tam is a Non-Executive Director and Deputy Director of Research with over 15 years of board level e

The UK consumer has been struggling with poor speeds, unreliable copper connections and mediocre customer service from faceless organisations for many years, as the government and Ofcom often highligh

Cityzenith CEO and Co-Founder Michael Jansen has made the Global Excellence Awards Top 40 CEOs list for 2021, ending the year with high praise for the inspiration he has provided the global business a

Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of a world-class
platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to
announce

Sydney, Australia 10th November 2021 — BodyMindLife Online is an emerging two sided marketplace supporting educators and teachers to connect with their students in the wellness sector was accepted in

Finexia is pleased to advise that the Dragonfly Biosciences initial public offer (IPO) is now open and accepting applications from the public. The company is seeking raise A$10M with the aim of listin

Sequince Capital operates the UK High Yield Income Fund, an Australian-domiciled fund targeting an annual income yield to investors of 10% net of fees, with quarterly income distributions, while seeki

Interest in the Altive Unicorns Fund continues to gather pace, with the firm reserving up to $30m of capacity in the fund for Morgan Stanley Wealth Management Australia. The allocation will be used to